Author:
van der Pol Jochem,Vöö Stefan,Bucerius Jan,Mottaghy Felix M.
Publisher
Springer Science and Business Media LLC
Subject
Radiology Nuclear Medicine and imaging,General Medicine,Radiology Nuclear Medicine and imaging,General Medicine
Reference66 articles.
1. Hung JC, Ponto JA, Hammes RJ. Radiopharmaceutical-related pitfalls and artifacts. Semin Nucl Med. 1996;26(4):208–55.
2. Tennvall J, Fischer M, Bischof Delaloye A, Bombardieri E, Bodei L, Giammarile F, et al. EANM procedure guideline for radio-immunotherapy for B-cell lymphoma with 90Y-radiolabelled ibritumomab tiuxetan (Zevalin). Eur J Nucl Med Mol Imaging. 2007;34(4):616–22. doi:
10.1007/s00259-007-0372-y
.
3. Silberstein EB, Buscombe, J.R., McEwan, A., Taylor, A.T.Jr.,.Society of Nuclear Medicine Procedure Guideline for Palliative Treatment of Painful Bone Metastases. Society of Nuclear Medicine Procedure Guidelines Manual. 2003:147–53.
4. Bodei L, Lam M, Chiesa C, Flux G, Brans B, Chiti A, et al. EANM procedure guideline for treatment of refractory metastatic bone pain. Eur J Nucl Med Mol Imaging. 2008;35(10):1934–40. doi:
10.1007/s00259-008-0841-y
.
5. Bodei L, Mueller-Brand J, Baum RP, Pavel ME, Horsch D, O’Dorisio MS, et al. The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours. Eur J Nucl Med Mol Imaging. 2013;40(5):800–16. doi:
10.1007/s00259-012-2330-6
.
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献